Get the Stockscreener App
0.3748
1.76%
-0.0067
After Hours:
.37
-0.0048
-1.28%
Gossamer Bio Inc Stock (GOSS) Forecast
The Gossamer Bio Inc (GOSS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.1588, representing a +475.99% increase from the current price of $0.3748. The highest analyst price target is $2.0904, and the lowest is $2.2272.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GOSS Price Target
Average 2.1886
(+483.93% Upside)
Is Gossamer Bio Inc (GOSS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.17 | Buy |
| STOCH(9,6) | 21.88 | Neutral |
| STOCHRSI(14) | 93.69 | Sell |
| MACD(12,26) | -0.2998 | Buy |
| ADX(14) | 51.14 | Sell |
| William %R | -78.37 | Neutral |
| CCI(14) | -52.75 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4148
Sell
|
0.423
Sell
|
| MA20 |
0.4543
Sell
|
0.6037
Sell
|
| MA50 |
1.482
Sell
|
1.2625
Sell
|
| MA100 |
2.2529
Sell
|
1.7752
Sell
|
| MA200 |
2.184
Sell
|
1.884
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GOSS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on GOSS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.17 indicates that GOSS is oversold. This indicates that GOSS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 21.88 indicates that GOSS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 93.69 indicates that GOSS is oversold. This suggests that GOSS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.14 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.75 indicates that GOSS is still oversold but not to an extreme extent.
Long-term GOSS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gossamer Bio Inc financial reports and earnings history, Gossamer Bio Inc (GOSS) stock could reach $17.72 by 2030, $12.78 by 2040 and $33.98 by 2050. See the projected annual prices until 2050 of the Gossamer Bio Inc stock below:
- Gossamer Bio Inc (GOSS) is expected to reach an average price of $4.0519 in 2035, with a high prediction of $4.7782 and a low estimate of $4.1239. This indicates an $981.08% rise from the last recorded price of $0.3748.
- Gossamer Bio Inc (GOSS) stock is projected to chart a bullish course in 2040, with an average price target of $12.25, representing an $3,168% surge from its current level. The forecast ranges from a conservative $12.45 to a sky-high $12.78.
- Our analysts predict Gossamer Bio Inc (GOSS) to jump 3,642% by 2045, soaring from $13.59 to an average price of $14.03, potentially reaching $13.54. While $13.59 is the low estimate, the potential upside is significant.
- Gossamer Bio Inc (GOSS) stock is expected to climb by 2050, reaching an average of $33.69, a $8,890% jump from its current level. However, a wide range of estimates exists, with high and low targets of $33.98 and $34.30, respectively, highlighting the market's uncertainty.
Gossamer Bio Inc Stock (GOSS) Year by Year Forecast
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2026
The predicted value for Gossamer Bio Inc (GOSS) in 2026 is set at an average of $2.2833. Estimates vary from a peak of $4.3541 to a trough of $0.2125, indicating an +509.21% surge from the present price of $0.3748.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $1.6533 | $2.2272 | $2.0904 | +341.11% |
| May, 2026 | $2.8561 | $2.9961 | $2.3797 | +662.05% |
| June, 2026 | $3.249 | $2.9008 | $2.8276 | +766.86% |
| July, 2026 | $3.0501 | $3.5036 | $3.0654 | +713.78% |
| August, 2026 | $2.5929 | $2.9829 | $2.7147 | +591.81% |
| September, 2026 | $2.984 | $3.0511 | $2.7458 | +696.15% |
| October, 2026 | $2.6168 | $3.2868 | $3.2204 | +598.19% |
| November, 2026 | $0.6897 | $0.9497 | $1.675 | +84.01% |
| December, 2026 | $2.2593 | $0.2125 | $3.7793 | +502.79% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gossamer Bio Inc (GOSS) is $3.4267, with a high forecast of $6.8522 and a low forecast of $0.0011. This indicates an +814.26% increase from the last price of $0.3748.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6664 | $1.6128 | $4.1646 | +611.42% |
| February, 2027 | $1.7436 | $1.2936 | $3.8468 | +365.20% |
| March, 2027 | $1.2225 | $0.3525 | $1.9853 | +226.17% |
| April, 2027 | $2.5796 | $0.5843 | $3.5896 | +588.27% |
| May, 2027 | $0.4132 | $0.055 | $2.5714 | +10.25% |
| June, 2027 | $0.8857 | $0.2239 | $1.1239 | +136.32% |
| July, 2027 | $0.2129 | $0.0011 | $1.3325 | -43.20% |
| August, 2027 | $0.58 | $0.2047 | $1.8665 | +54.76% |
| September, 2027 | $0.311 | $0.801 | $0.9868 | -17.01% |
| October, 2027 | $0.9739 | $0.8592 | $0.8439 | +159.84% |
| November, 2027 | $0.2933 | $0.0367 | $1.5933 | -21.75% |
| December, 2027 | $6.7622 | $0.5349 | $6.8522 | +1,704% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2028
In 2028, Gossamer Bio Inc (GOSS) is projected to reach an average price of $5.1826, with a high projection of $8.2108 and a low estimate of $2.1544. This indicates an +1,283% rise from the last price of $0.3748.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.4294 | $6.214 | $8.2108 | +1,882% |
| February, 2028 | $5.3665 | $4.9747 | $8.1911 | +1,332% |
| March, 2028 | $4.7954 | $3.8637 | $7.1233 | +1,179% |
| April, 2028 | $2.8726 | $2.6308 | $5.0872 | +666.43% |
| May, 2028 | $3.8485 | $2.1544 | $3.678 | +926.81% |
| June, 2028 | $3.5113 | $3.4831 | $3.3749 | +836.85% |
| July, 2028 | $2.9542 | $2.7943 | $2.9144 | +688.20% |
| August, 2028 | $3.6352 | $3.1924 | $3.2188 | +869.91% |
| September, 2028 | $3.6081 | $3.5799 | $3.5417 | +862.67% |
| October, 2028 | $3.0909 | $3.2309 | $3.3863 | +724.69% |
| November, 2028 | $2.832 | $2.952 | $2.8288 | +655.60% |
| December, 2028 | $2.6948 | $2.7266 | $2.7602 | +619.01% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2029
The 2029 price forecast for Gossamer Bio Inc Stock (GOSS) is $8.9346 on average, with a high prediction of $17.86 and a low estimate of $0.00441. This represents an +2,284% increase from the previous price of $0.3748.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.2359 | $2.3259 | $2.3831 | +496.56% |
| February, 2029 | $2.3188 | $2.2641 | $2.2588 | +518.67% |
| March, 2029 | $2.1712 | $2.1952 | $2.152 | +479.30% |
| April, 2029 | $2.1984 | $2.206 | $2.1391 | +486.54% |
| May, 2029 | $2.0117 | $2.0415 | $2.1609 | +436.75% |
| June, 2029 | $1.4424 | $1.505 | $1.6337 | +284.84% |
| July, 2029 | $1.1287 | $1.1748 | $1.1166 | +201.15% |
| August, 2029 | $0.8923 | $0.9321 | $0.9494 | +138.07% |
| September, 2029 | $0.1851 | $0.4051 | $0.7505 | -50.60% |
| October, 2029 | $0.1738 | $0.0302 | $0.322 | -53.63% |
| November, 2029 | $0.1453 | $0.00441 | $0.2456 | -61.25% |
| December, 2029 | $18.14 | $0.0537 | $17.86 | +4,740% |
Gossamer Bio Inc Stock (GOSS) Price Forecast for 2030
Gossamer Bio Inc Stock (GOSS) is expected to reach an average price of $14.85 in 2030, with a high forecast of $21.23 and a low forecast of $8.4733. This signifies an +3,862% surge from the last price of $0.3748.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.59 | $18.17 | $17.72 | +4,326% |
| February, 2030 | $15.98 | $15.80 | $14.95 | +4,164% |
| March, 2030 | $17.65 | $16.60 | $15.64 | +4,609% |
| April, 2030 | $14.81 | $18.07 | $16.71 | +3,853% |
| May, 2030 | $18.09 | $15.65 | $17.75 | +4,726% |
| June, 2030 | $15.76 | $19.40 | $17.98 | +4,104% |
| July, 2030 | $8.959 | $11.86 | $13.02 | +2,290% |
| August, 2030 | $17.42 | $8.4733 | $15.49 | +4,549% |
| September, 2030 | $18.71 | $17.81 | $17.52 | +4,892% |
| October, 2030 | $17.63 | $17.70 | $18.41 | +4,605% |
| November, 2030 | $21.77 | $17.88 | $19.39 | +5,709% |
| December, 2030 | $21.23 | $21.58 | $21.23 | +5,564% |
0.04%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):